IRIS
BITTONI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.425
EU - Europa 1.548
AS - Asia 1.357
SA - Sud America 356
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.370
SG - Singapore 505
BR - Brasile 291
IT - Italia 282
VN - Vietnam 252
CN - Cina 251
RU - Federazione Russa 226
UA - Ucraina 202
SE - Svezia 168
DE - Germania 160
IE - Irlanda 119
TR - Turchia 104
FI - Finlandia 88
FR - Francia 80
DK - Danimarca 72
HK - Hong Kong 69
GB - Regno Unito 68
CI - Costa d'Avorio 60
IN - India 46
KR - Corea 40
NL - Olanda 32
MA - Marocco 27
CA - Canada 22
MX - Messico 22
JP - Giappone 21
BD - Bangladesh 19
AR - Argentina 17
ZA - Sudafrica 17
EC - Ecuador 15
CO - Colombia 14
ES - Italia 13
PL - Polonia 11
IQ - Iraq 9
BE - Belgio 8
ID - Indonesia 7
DZ - Algeria 6
MY - Malesia 6
CL - Cile 5
UY - Uruguay 5
VE - Venezuela 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
Totale 6.817
Salva come PNG Salva come JPEG
Città #
Ashburn 620
Singapore 324
Chandler 286
Jacksonville 214
Fairfield 210
San Jose 161
Wilmington 135
Dallas 122
Boardman 118
Dublin 118
New York 110
Woodbridge 103
Ann Arbor 95
Seattle 94
Houston 92
Des Moines 76
Cambridge 72
Ho Chi Minh City 70
Beijing 69
Centro 67
Hanoi 66
Hong Kong 64
Abidjan 60
Los Angeles 55
Moscow 49
The Dalles 49
Lawrence 47
Munich 47
Princeton 47
San Mateo 47
Lauterbourg 37
Turin 33
Turku 33
Orem 26
Tokyo 19
Buffalo 18
London 18
San Diego 18
São Paulo 18
Helsinki 17
Hefei 16
Atlanta 15
Frankfurt am Main 15
Santa Clara 15
Chennai 14
Amsterdam 13
Brooklyn 13
Johannesburg 13
Chicago 12
Da Nang 12
Stockholm 12
Haiphong 11
Pune 11
Rome 11
Montreal 10
Rio de Janeiro 10
Warsaw 9
Brussels 8
Curitiba 8
Denver 8
Guayaquil 8
Poplar 8
Brasília 7
Fortaleza 7
Guangzhou 7
Manchester 7
Milan 7
St Petersburg 7
Washington 7
Wuhan 7
Wuxi 7
Belo Horizonte 6
Biên Hòa 6
Cagliari 6
Mexico City 6
Porto Alegre 6
San Francisco 6
Bogotá 5
Council Bluffs 5
Montevideo 5
Paris 5
Santiago 5
Bến Tre 4
City of London 4
Columbus 4
Dhaka 4
Falls Church 4
Florence 4
Izmir 4
Miami 4
Mumbai 4
Nanjing 4
New Bedfont 4
Nuremberg 4
Olomouc 4
Prescot 4
Quito 4
Salt Lake City 4
Shanghai 4
Shenzhen 4
Totale 4.372
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 210
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 199
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 197
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 194
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 181
Optimal management of resected gastric cancer 179
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 177
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 174
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 169
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 166
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 164
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 161
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 160
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 156
HER family receptor expression and prognosis in pancreatic cancer 156
Medical treatment for cholangiocarcinoma 153
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 152
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 152
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 149
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 147
Panitumumab for the treatment of metastatic colorectal cancer: A review 144
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 144
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 143
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 141
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 140
Trattamento del carcinoma del pancreas. Attualità e prospettive 139
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 135
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 134
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 133
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 133
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 128
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 128
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 127
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 127
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 123
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 123
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 123
Palliative treatment 117
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 114
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 108
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 104
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 103
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 103
Selecting the best treatment for an individual patient. 103
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 88
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 77
Totale 6.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 105 80 42
2021/2022389 29 94 6 8 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025987 148 77 20 21 64 49 99 35 162 71 133 108
2025/20262.505 209 184 132 309 379 208 417 259 210 198 0 0
Totale 6.906